In the placebo group, the tumors grew aggressively in average crosssection from 1.36 cm2 to 2.74 cm2 on the last day of treatment (grey graph). The tumors size increased 101.4%. In the group that received the triple therapy, the tumor increase in size by 52.8%. The average tumor was 1.25 cm2 at the beginning of the therapy and grew up to 1.91 cm2 at the end (black graph). The therapy resulted in a reduction of the increase in tumor size of 48.6% (p ≤ 0.05).